Polomar Health Services (PMHS) EBITDA (2022 - 2026)
Polomar Health Services (PMHS) posted EBITDA of $218377.0 for Q2 2026, up 3263.97% on a QoQ basis from -$6902.0 in Q1 2026, and up 138.77% year-over-year from $91461.0 in Q2 2025.
Powered by 
Analysis
Polomar Health Services (PMHS) EBITDA (2022 - 2026) Analysis & Trends
Polomar Health Services has reported EBITDA for 5 years, with the latest figure at $218377.0 in Q2 2026.
- On a quarterly basis, EBITDA rose 138.77% year-over-year to $218377.0 in Q2 2026; TTM through Jun 2026 was -$9.4 million, a 385.72% decrease from a year earlier, with the FY2025 full-year figure at -$10.6 million, down 711.87% from the prior year.
- EBITDA was $218377.0 for Q2 2026 at Polomar Health Services, up from -$6902.0 in the prior quarter.
- The five-year high for EBITDA was $218377.0 in Q2 2026, with the low at -$8.9 million in Q4 2025.
- Average EBITDA over 5 years is -$763359.8, with a median of -$156222.5 recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: EBITDA sank 1197.72% in 2025, then soared 138.77% in 2026.
- Over 5 years, EBITDA stood at -$151977.0 in 2022, then soared by 37.8% to -$94537.0 in 2023, then plunged by 628.93% to -$689112.0 in 2024, then tumbled by 1197.72% to -$8.9 million in 2025, then soared by 102.44% to $218377.0 in 2026.
- The last three EBITDA figures came in at $218377.0 (Q2 2026), -$6902.0 (Q1 2026), and -$8.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -231.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 6.30 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 39.97 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 129.77 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 740.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -73.42 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 40.46 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 39.73 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 1.74 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 218,377.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 218,377.00 |
| Mar 31, 2026 | -6,902.00 |
| Dec 31, 2025 | -8.94 Mn |
| Sep 30, 2025 | -628,808.00 |
| Jun 30, 2025 | -563,333.00 |
| Mar 31, 2025 | -415,408.00 |
| Dec 31, 2024 | -689,112.00 |
| Sep 30, 2024 | -259,173.00 |
| Jun 30, 2024 | -190,742.00 |
| Mar 31, 2024 | -160,468.00 |
| Dec 31, 2023 | -94,537.00 |
| Sep 30, 2023 | -134,678.00 |
| Jun 30, 2023 | -90,958.00 |
| Mar 31, 2023 | -89,806.00 |
| Dec 31, 2022 | -151,977.00 |
| Sep 30, 2022 | -13,518.00 |